Cisplatin-vinorelbine as first line chemotherapy in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes: Results of a retrospective analysis

被引：0
|
作者：
Raafat, J. [1 ]
Mourad, C. [2 ]
机构：
[1] Canc Res Ctr, Inst Canc, Tehran, Iran
[2] Pierre Fabre Medicament, Div Oncol, Beirut, Lebanon
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [1] Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines
    Vassilomanolakis, M
    Koumakis, G
    Barbounis, V
    Demiri, M
    Pateras, H
    Efremidis, AP
    ANNALS OF ONCOLOGY, 2000, 11 (09) : 1155 - 1160
  • [2] Second-Line Combination Chemotherapy with Vinorelbine and Capecitabine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines and/or Taxanes
    Mao, Weidong
    Guan, Xunxing
    Tucker, Steven
    Li, Fengyan
    He, Zhenyu
    Wang, Junjie
    Guo, Jun
    Wu, Shangang
    CHEMOTHERAPY, 2011, 57 (01) : 71 - 76
  • [3] Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes
    Alison Jones
    Mary O’Brien
    Harald Sommer
    Elzbieta Nowara
    Anja Welt
    Tadeusz Pienkowski
    Janusz Rolski
    My-Linh Pham
    Kevin Perraud
    Véronique Trillet-Lenoir
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 755 - 763
  • [4] Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes
    Jones, Alison
    O'Brien, Mary
    Sommer, Harald
    Nowara, Elzbieta
    Welt, Anja
    Pienkowski, Tadeusz
    Rolski, Janusz
    Pham, My-Linh
    Perraud, Kevin
    Trillet-Lenoir, Veronique
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (04) : 755 - 763
  • [5] A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
    Suo, Jiaojiao
    Zhong, Xiaorong
    He, Ping
    Zheng, Hong
    Tian, Tinglun
    Yan, Xi
    Luo, Ting
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] CISPLATIN, CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL (PCMF) AS FIRST LINE THERAPY OF METASTATIC TRIPLE NEGATIVE BREAST CANCER (MTNBC) IN PATIENTS PREVIOUSLY TREATED WITH ADJUVANT ANTHRACYCLINES AND TAXANES: RETROSPECTIVE ANALYSIS
    Donat, D. A.
    ANNALS OF ONCOLOGY, 2012, 23 : 137 - 138
  • [7] Evolving Approaches to Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes
    Murphy, Conleth G.
    Seidman, Andrew D.
    CLINICAL BREAST CANCER, 2009, 9 : S58 - S65
  • [8] Pegylated Liposomal Doxorubicin (Caelyx®) and Oral Vinorelbine in First-Line Metastatic Breast Cancer Patients Previously Treated with Anthracyclines
    Livi, L.
    Meattini, I.
    Scotti, V.
    Cardillo, C. De Luca
    Galardi, A.
    Iermano, C.
    Sanchez, L.
    Nori, J.
    Mangoni, M.
    Franzese, C.
    Orzalesi, L.
    Bertocci, S.
    Agresti, B.
    Masoni, T.
    Bianchi, S.
    Cataliotti, L.
    Biti, G.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (03) : 158 - 162
  • [9] Bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
    Schmid, P
    Schippinger, V
    Kiewe, P
    Lange, W
    Preiss, J
    Niederle, N
    Brossart, P
    Freier, W
    Van de Velde, H
    Possinger, K
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S68 - S69
  • [10] Phase II study of vinorelbine (NVB) and UFT in patients with metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes.
    Anton, A
    Puertolas, T
    Ramos, M
    Barnadas, A
    Florian, J
    Grande, R
    Ribelles, N
    Lomas, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 64S - 64S
12345